Fate Therapeutics

FATE

Market cap $172M

Overview Fund Trends Analyst Outlook Journalist POV

1.49 USD

--0.04

2.61%

At close Updated Oct 22, 4:00 PM EDT

Pre-market

After hours

1.51

+0.02

1.34%

1 day

-2.61%

5 days

-1.97%

1 month

47.52%

3 months

20.16%

6 months

8.76%

Year to date

-16.76%

1 year

-53.29%

5 years

-96.88%

10 years

-54.43%

About: Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Employees: 181

Healthcare Biotechnology